News | June 23, 2014

New Study Sheds Light on Risk Factors for Atrial Fibrillation and Cardioembolic Stroke

June 23, 2014 — Researchers have announced the results of a four-year study that used 3-D echocardiography to examine the role of mid left atrial cross sectional area (LACSA) as a risk factor for cardioembolic (CE) stroke, atrial fibrillation (AF) and stroke recurrence. Atrial fibrillation is a common heart problem, affecting 2.6 million Americans per year. Strokes resulting from atrial fibrillation and heart disease are typically more severe, as they are associated with significant debilities and higher death rates.

“One of the challenges in treating patients with heart disease and AF is predicting which patients are at higher risk for stroke. Our study identifies a novel imaging sign that can be obtained with echocardiography, a common medical diagnostic tool that uses ultrasound to image the heart, in order to improve our ability to predict which patients are at greater risk for stroke,” said primary investigator Timothy C. Tan, Ph.D., MBBS, clinical and research fellow at Massachusetts General Hospital. “Ultimately, this may help physicians develop more targeted and effective treatment plans for patients with heart disease and AF.”

Tan and his colleagues first used 3-D echo and customized software to analyze a small cohort of 40 ischemic stroke patients, to compare left atrial (LA) remodeling between patients with AF and those without AF. Those results, combined with flow dynamics analysis, allowed the researchers to derive a simplified echocardiographic parameter using 2-D echo measurements to calculate LACSA. Finally, the researchers validated their new formula in a separate group of 1,275 ischemic stroke patients.

Researchers on the study, “Left Atrial Cross Sectional Area, a Marker of Left Atrial Shape, is a Novel Risk Factor for Cardioembolic Stroke and Recurrence of Ischemic Stroke,” included Tan, Octavio Pontes-Neto, Mark Handschumacher, Maria C. Nunes, Yong-Hyun Park, Victoria Piro, Yuan Jiao, Gyeong-Moon Kim, Johanna Helenius, Cashel O'Brien, Xin Zeng, Karen Furie, Hakan Ay and Judy Hung from Massachusetts General Hospital in Boston.

The results of the study were presented at the 25th annual scientific sessions of the American Society of Echocardiography (ASE) in Portland, Ore.

For more information: www.asecho.org

Related Content

News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
GE’s blood speckle imaging (BSI) software shows the flow of blood cells’ trajectories. It is a form of blood vector flow imaging.

GE’s blood speckle imaging (BSI) software offers the ability to view a graphical representation of the blood cells’ trajectories.

News | Cardiovascular Ultrasound| September 01, 2017
Cardiologists are constantly on the lookout for new methods to examine the heart using new imaging technology advance
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init